Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$56,000.00

Amorphous Solid Solutions in Glassy Hydrogels for Enhancing the Delivery of Poorly Soluble Drugs

EF 2023-24

Résumé
One major challenge in oral drug delivery has been the low bioavailability of many crystalline compounds exhibiting poor solubility characteristics. Traditional methods for solubility enhancement involving solubilizing agents (e.g. co-solvents & surfactants) and particle size reduction have not always been successful. On the other hand, the creation of solid solutions (molecular dispersions) in soluble polymers has shown potential to be effective in enhancing the dissolution and oral bioavailability due to the higher solubility of the amorphous drug (supersaturation). However, the mechanisms of drug dissolution and release from amorphous solid solutions and their effect on the overall time evolution of supersaturation during dissolution are not well understood and have not been fully explored. In addition, physical instability of these systems during storage such as crystallization on aging has limited their success in commercial applications. Furthermore, no criterion exists in determining the threshold drug loading level above which crystallization may occur in these soluble polymers. Despite the ongoing interest in hydrogels as biomaterials and carriers for controlled drug release, the novel application of cross-linked glassy hydrogels for stabilizing the loaded drug in an amorphous state has not been fully investigated. Cross-linked hydrogels are more advantageous than soluble polymers in this regard since the three-dimensional network in the glassy state is more effective in preventing the crystallization of loaded amorphous drug. Experimental evidence suggests that solid solutions based on hydrogels can also avoid peaks and valleys in the kinetic solubility profiles normally associated with solid solutions based on soluble polymers, thereby achieving a more sustained drug supersaturation than conventional systems based on soluble polymers. We therefore propose to conduct an in-depth investigation of this hydrogel-based system and identify the optimal range of design parameters that can effectively inhibit the crystallization of loaded drug and maximize the supersaturation maintenance to enhance the delivery of poorly soluble drugs.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2019-05459
Name nom
Lee, Ping
Department département
Pharmaceutical Sciences, Graduate Department of - Pharmaceutical Sciences, Graduate Department of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
56000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1805
Research subject group en
Chemical engineering
Research subject group fr
Transport processes
Research subject en
Génie chimique
Research subject fr
Procédés de transfert
Application title
Amorphous Solid Solutions in Glassy Hydrogels for Enhancing the Delivery of Poorly Soluble Drugs
Keyword
Amorphous Solid Solutions/Dispersions; Crystallization Kinetics; Effect of Drug Loading; Effect of Polymer Swelling; Hydrogels; Kinetic Solubility; Phase Separation; Poorly Water-Soluble Drugs; Solubility Enhancement; Supersaturation Rate
Application summary
One major challenge in oral drug delivery has been the low bioavailability of many crystalline compounds exhibiting poor solubility characteristics. Traditional methods for solubility enhancement involving solubilizing agents (e.g. co-solvents & surfactants) and particle size reduction have not always been successful. On the other hand, the creation of solid solutions (molecular dispersions) in soluble polymers has shown potential to be effective in enhancing the dissolution and oral bioavailability due to the higher solubility of the amorphous drug (supersaturation). However, the mechanisms of drug dissolution and release from amorphous solid solutions and their effect on the overall time evolution of supersaturation during dissolution are not well understood and have not been fully explored. In addition, physical instability of these systems during storage such as crystallization on aging has limited their success in commercial applications. Furthermore, no criterion exists in determining the threshold drug loading level above which crystallization may occur in these soluble polymers. Despite the ongoing interest in hydrogels as biomaterials and carriers for controlled drug release, the novel application of cross-linked glassy hydrogels for stabilizing the loaded drug in an amorphous state has not been fully investigated. Cross-linked hydrogels are more advantageous than soluble polymers in this regard since the three-dimensional network in the glassy state is more effective in preventing the crystallization of loaded amorphous drug. Experimental evidence suggests that solid solutions based on hydrogels can also avoid peaks and valleys in the kinetic solubility profiles normally associated with solid solutions based on soluble polymers, thereby achieving a more sustained drug supersaturation than conventional systems based on soluble polymers. We therefore propose to conduct an in-depth investigation of this hydrogel-based system and identify the optimal range of design parameters that can effectively inhibit the crystallization of loaded drug and maximize the supersaturation maintenance to enhance the delivery of poorly soluble drugs.